Adjuvant trial in melanoma patients comparing rIFN-alpha to rIFN-gamma to Iscador to a control group after curative resection of high risk primary (>= 3MM) or regional lymphnode metastasis (EORTC 18871)

Kleeberg, U., Brocker, E., Lejeune, F., Chartier, C., Egger, C., Marsden, J., Ruiter, D., & Suciu, S. (1999). Adjuvant trial in melanoma patients comparing rIFN-alpha to rIFN-gamma to Iscador to a control group after curative resection of high risk primary (>= 3MM) or regional lymphnode metastasis (EORTC 18871). European Journal of Cancer, 35, S82-S82. https://doi.org/10.1016/S0959-8049(99)80697-2 (Original work published 1999)